<DOC>
	<DOCNO>NCT01895920</DOCNO>
	<brief_summary>This project aim characterize HIV-1 viral biofilms structural functional property decipher role new viral reservoir new mode viral spread . The prospective national study conduct cell isolated blood sample 20 patient infected HIV .</brief_summary>
	<brief_title>Viral Biofilms : Hijacking T Cell Extracellular Matrix Regulate HIV-1 Spread ?</brief_title>
	<detailed_description>The investigator ' preliminary data indicate besides `` free `` infectious viral particle , HIV-1 infect cluster differentiation 4 ( CD4+ ) lymphocytes also produce extracellular viral assembly wrap extracellular matrix cocoon tightly bind surface cell . Importantly , structure infectious , transfer target cell upon intercellular contact key role HIV-1 spread T lymphocytes . HIV-1 viral biofilm could important direct transmission virion also `` trans-infection `` , process objective : - good characterize molecular composition architecture biofilm ( use proteomics , glycomic superresolution cell image approach ) regard property ( infectivity , adhesiveness , protection virion ) determine whether cell infect patient produce structure . - delineate viral factor regulate formation new infectious structure ( particular attention Tat , Vpu Nef HIV-1 encode use mutant virus expression vector ) . - investigate lymphocyte pathway regulate viral biofilms formation composition extracellular matrix ( ECM ) proteins ( use quantitative polymerase chain reaction ( qPCR ) siRNA ) . - determine whether viral biofilms involve HIV-1 transmission transinfection - study contribution infectious structure dynamic transmission lymph node . This project may contribute decipher role viral biofilms HIV-1 transmission . Ultimately , intend determine interference retroviral infection T cell activation pathways modulates pattern ECM production T cell , tune viral biofilm composition regulate viral dissemination .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Age â‰¥ 18 year able give write consent HIV positive serology HIV1 Viral load &gt; 10 000 copies/ml CD4 T cell &gt; 100 cells/mm3 Treated antiretroviral therapy ( ARV ) less 6 month Covered French Social Security Involved clinical trial Pregnancy ( inclusion postpone ) No covered French Social Security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Biofilm</keyword>
	<keyword>Transmission</keyword>
</DOC>